Viewing Study NCT01347866


Ignite Creation Date: 2025-12-24 @ 4:00 PM
Ignite Modification Date: 2026-01-01 @ 10:39 PM
Study NCT ID: NCT01347866
Status: TERMINATED
Last Update Posted: 2018-10-29
First Post: 2011-05-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced metastatic cancer (solid tumors) View
None PI3K View
None mTOR View
None MEK View